Menu
Back to Journals » Clinical Ophthalmology » Volume 5
Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
Authors Wingard JB, Mah F
Published 15 February 2011 Volume 2011:5 Pages 201—207
DOI https://doi.org/10.2147/OPTH.S8665
Review by Single anonymous peer review
Peer reviewer comments 2
Jeremy B Wingard, Francis S Mah
UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Abstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular itching associated with allergic conjunctivitis. Several clinical studies have demonstrated its safety as well as its efficacy versus placebo. This review finds that bepotastine besilate 1.5% solution is a suitable alternative to other agents within the class of H1-antihistamines, but there are no clinical trial data to suggest that it holds any specific advantages over other agents.
Keywords: allergic conjunctivitis, antihistamine, ocular itching
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.